Medullary thyroid carcinoma

Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis

Posted on March 4, 2019July 28, 2022 by admin

ORIGINAL ARTICLE

Hippokratia 2013, 17(3):246-251

Vainas I, Marthopoulos A, Chrisoulidou A, Raptou K, Tziomalos K<, Pazaitou-Panayiotou K
Department of Endocrinology-Endocrine Oncology, Theagenion Cancer Hospital, Endocrinology Outpatient Clinic, Euromedica Clinic, Department of Nuclear Medicine, Theagenion Cancer Hospital, 1st Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital , Thessaloniki, Greece

Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.

Posted on March 4, 2019July 26, 2022 by admin

ORIGINAL ARTICLE

Hippokratia 2014, 18(2):130-134

Prokopakis E, Doulaptsi M, Kaprana A, Velegrakis S, Vlastos Y, Velegrakis G
Department of Otorhinolaryngology, University Hospital of Heraklion, Heraklion Crete, Greece

The results of molecular genetic testing for RET proto-oncogene mutations in patients with medullary thyroid carcinoma in a referral center after the two decade period

Posted on February 28, 2019July 22, 2022 by admin

RESEARCH ARTICLE

Hippokratia 2016, 20(3):187-191

Rovcanin B, Damjanovic S, Zivaljevic V, Diklic A, Jovanovic M, Paunovic I
Center for Endocrine Surgery, Institute of Endocrinology, Diabetes and Metabolic Disease, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.